Do you want to read an article? Please log in or register.
Endobronchial coil therapy in severe emphysema: 6-month outcomes from a Swiss National Registry
COMMENTED
Related content
RECOMMENDED
Emphysema
Quantifying patient centered outcomes associated with the use of bilateral endobronchial coil treatment in patients with severe emphysema
Curr Med Res Opin.
Evans R, Brutsche M, Busca R, Deslee G, de Soyza A, Fellrath JM, Franzen D, Hartman J, Mealing S, Morton T, Munavvar M, Sculpher M, Shah PL, Slebos DJ, Durand-Zaleski I
doi: 10.1080/03007995.
RECOMMENDED
Emphysema
Predictors of Response to Endobronchial Coil Therapy in Patients with Advanced Emphysema
Chest.
Slebos DJ, Cicenia J, Sciurba FC, Criner GJ, Hartman JE, Garner J, Deslée G, Delage A, Jantz M, Marquette CH, Strange C, Hatipoglu U, Mehta AC, LaPrad AS, Schmid-Bindert G, Herth F, Shah PL; RENEW Study Group
doi: 10.1016/j.chest.2019.02.012.
RECOMMENDED
AsthmaCOPDPneumonia
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, Ni F, Fang S, Lu Y, Ding X, Liu H, Ewing RM, Jones MG, Hu Y, Nie H, Wang Y
doi: 10.1016/S2213-2600(21)00174-0
RECOMMENDED
Emphysema
Long-term follow up after endoscopic valve therapy in patients with severe emphysema
Ther Adv Respir Dis.
Gompelmann D, Heinhold T, Rötting M, Bischoff E, Kontogianni K, Eberhardt R, Herth FJF
doi: 10.1177/1753466619866101.
Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial.
Lancet Respir Med.
Herth FJ, Valipour A, Shah PL, Eberhardt R, Grah C, Egan J, Ficker JH, Wagner M, Witt C, Liebers U, Hopkins P, Gesierich W, Phillips M, Stanzel F, McNulty WH, Petermann C, Snell G, Gompelmann D
doi: 10.1016/
Endoscopic Valve Removal >180 Days since Implantation in Patients with Severe Emphysema
Respiration.
Gompelmann D, Gerovasili V, Kontogianni K, Schuhmann M, Eberhardt R, Herth FJF, Polke M
doi: 10.1159/000489887.
RECOMMENDED
Asthma
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax
Jackson DJ, Busby J, Pfeffer PE, Menzies-Gow A, Brown T, Gore R, Doherty M, Mansur AH, Message S, Niven R, Patel M, Heaney LG, UK Severe Asthma Registry.
doi: 10.1136/thoraxjnl-2020-215168
Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety
Respir Med.
Mansur AH, Srivastava S, Mitchell V, Sullivan J, Kasujee I
doi: 10.1016/j.rmed.2017.01.008.
COMMENTED
COPD
A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE)
Am J Respir Crit Care Med.
Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, Sciurba FC, Shah PL, Wahidi MM, de Oliveira HG, Morrissey B, Cardoso PFG, Hays S, Majid A, Pastis N Jr, Kopas L, Vollenweider M, McFadden PM, Machuzak M, Hsia DW, Sung A, Jarad N, Kornaszewska M, Hazelrigg S, Krishna G, Armstrong B, Shargill NS, Slebos DJ; LIBERATE Study Group
doi: 10.1164/rccm.